Ted Buchan & Co’s AbbVie ABBV Stock Holding History

Ted Buchan & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$410K	Sell	1,568 -19	-1%	-$4.87K	0.14%	74
2026 Q2	$399K	Hold	1,587	–	–	0.13%	72
2026 Q1	$345K	Hold	1,587	–	–	0.13%	68
2025 Q4	$363K	Sell	1,587 -13	-0.8%	-$2.96K	0.13%	71
2025 Q3	$370K	Buy	1,600 +13	+0.8%	+$2.65K	0.15%	67
2025 Q2	$295K	Hold	1,587	–	–	0.12%	83
2025 Q1	$333K	Hold	1,587	–	–	0.16%	71
2024 Q4	$282K	Hold	1,587	–	–	0.13%	78
2024 Q3	$313K	Hold	1,587	–	–	0.15%	74
2024 Q2	$272K	Hold	1,587	–	–	0.15%	75
2024 Q1	$289K	Hold	1,587	–	–	0.18%	76
2023 Q4	$246K	Sell	1,587 -45	-3%	-$6.56K	0.18%	74
2023 Q3	$243K	Hold	1,632	–	–	0.2%	68
2023 Q2	$220K	Hold	1,632	–	–	0.17%	77
2023 Q1	$260K	Buy	1,632 +80	+5%	+$12.2K	0.22%	65
2022 Q4	$251K	Buy	+1,552	New	+$238K	0.23%	63

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Ted Buchan & Co's ABBV Position: Q3 2026 in Review

Ted Buchan & Co reduced its AbbVie (ABBV) stake by 1.2% in Q3 2026, selling an estimated $4.87K and leaving 1,568 shares worth $410K. The position accounts for 0.14% of the portfolio, ranked #74.

Ted Buchan & Co first reported a position in ABBV in Q4 2022 and has held it in 16 quarters since. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Ted Buchan & Co held 1,568 shares of AbbVie worth $410K as of Q3 2026.
Ted Buchan & Co sold 19 AbbVie shares in Q3 2026, an estimated $4.87K.
AbbVie made up 0.14% of Ted Buchan & Co's portfolio in Q3 2026, its #74 holding.
Ted Buchan & Co first reported a position in AbbVie in Q4 2022 and has held it in 16 quarters since.
1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Ted Buchan & Co's 13F filing for Q3 2026, filed 23 Oct 2026.